Latest Biotech News

Nanobiotix secured $71 million in non‑dilutive financing from HealthCare Royalty to support the late‑stage development of its radiotherapy‑activated nanotherapy partnered with Johnson & Johnson....

Eli Lilly reported tirzepatide (Mounjaro/Zepbound) sales exceeding $10 billion for the third quarter, prompting the company to raise revenue guidance. The blockbuster performance cements...

Researchers demonstrated a scalable pipeline to produce thousands of human kidney organoids and integrate them into ex vivo perfused porcine kidneys, then perform the first transplants of porcine...

MIT teams published preclinical data showing polymer‑coated nanoparticles that deliver IL‑12 directly to ovarian tumors can convert immunologically cold lesions into responsive ones and, when...

A joint UCL–UCLA gene therapy program reported multi‑year follow‑up data showing a gene therapy for ADA‑SCID restored immune function in treated children with a 95% success rate and no major...

Novo Nordisk submitted a higher unsolicited offer for obesity biotech Metsera, prompting an immediate legal and strategic response from Pfizer. Novo’s bid raises the deal value well above Pfizer’s...

The FDA placed a clinical hold on two Phase 3 trials of Intellia Therapeutics’ CRISPR candidate nexiguran ziclumeran after a participant experienced severe liver enzyme elevations and...

Researchers developed a scalable method to produce thousands of human kidney organoids and demonstrated integration with perfused porcine kidneys ex vivo, culminating in the first transplant of...

Google unveiled an AI-led discovery claiming a validated new cancer drug combination generated by its Cell2Sentence-Scale model family, signaling rapid advances in foundation models applied to...

A wave of ventures pursuing heritable genome editing emerged, with one U.S. entrepreneur raising significant early funding to study the ethics and feasibility of gene-edited embryos. At the same...

Dana-Farber researchers identified interferon‑gamma signaling within tumor-associated myeloid cells as a driver of resistance to immune checkpoint inhibitors in renal cell carcinoma, revealing a...

MIT and collaborators engineered polymer-coated nanoparticles that deliver IL‑12 directly to ovarian tumors and demonstrated robust antitumor responses when combined with checkpoint inhibitors. In...

Eli Lilly expanded distribution for its GLP‑1 tirzepatide obesity drug Zepbound by enabling retail pharmacy pick-up at Walmart through its LillyDirect platform, broadening access beyond home...

Guardant Health launched its Shield multi‑cancer detection (MCD) test into broader clinical use and signaled plans to gather real‑world adoption data for multi-cancer screening, while Diasorin...

ADC developer Tubulis expanded its Series C to $401 million to accelerate proprietary antibody‑drug conjugate programs, reflecting investor appetite for differentiated oncology platforms....

Novo Nordisk launched a surprise unsolicited bid for Metsera that outvalues Pfizer’s previously agreed acquisition, setting off a rapid escalation in the obesity M&A sweepstakes. Novo offered...

Regulators put two late‑stage clinical trials of Intellia Therapeutics’ CRISPR therapy nexiguran ziclumeran on formal hold after a participant developed severe liver injury, deepening scrutiny of...

Teams led by the Institute for Bioengineering of Catalonia and collaborators reported a reproducible, scalable method to generate thousands of human kidney organoids and successfully integrate...

Two preclinical findings offer complementary routes to improve checkpoint immunotherapy. MIT engineers reported polymer‑coated nanoparticles that deliver IL‑12 directly into ovarian tumors; in...

AI is moving from hypothesis generation toward actionable biomedical outputs. Google announced a large foundation model that proposed a novel cancer drug combination which the company validated...